🔹Normal range (2.5-4.5 mg/dL),
🔹Plasma phosphate concentration < 2.5 mg/dL or 0.81 mmol/L
CAUSES:
🔹Poor Nutrition
🔹Chronic Alcoholism
🔹Diarrhoea
🔹Beta 2 Agonists
🔹Insulin
🔹Acetazolamide
🔹Hemodialysis
🔹Hyperparathyroidism
EFFECTS
🔹Irritability
🔹Confusion
🔹Metabolic encephalopathy
🔹Coma
🔹Muscle weakness
🔹Respiratory failure
🔹Failure to wean from ventilator
🔹Dysphagia
🔹Ileus
🔹cardiac arrhythmias and cardiomyopathy.
🔹ODC shift to left
TREATMENT
🔹Asymptomatic mild-to-moderate hypophosphatemia (1-2.5 mg/dL) can be treated with oral phosphate supplementation if the gastrointestinal tract is intact.
🔹Symptomatic or severe hypophosphatemia (< 1.0 mg/dL) should be treated with intravenous phosphate.
🔹Oral supplementation : 2.5 to 3.5 g (80 to 110 mmol) per day, divided over two to three doses.
Intravenous:
🔹The required dose of initial intravenous phosphate may vary from 2.5 to 19.8 mg/kg.
Typically, 2-5 mg/kg of inorganic phosphate dissolved in 0.45% saline is given over 6-12 hours and repeated as needed.
🔹Rapid or large infusions are dangerous : Large intravenous doses of phosphate may result in hyperphosphatemia, hypomagnesemia, hypocalcemia, and hypotension.
🔹Hyperkalemia is prevented by using sodium phosphate instead of potassium phosphate in patients with potassium levels >4 mmol/L.
🔹Do not mix with Calcium or Magnesium
🔹Daily Phosphate level monitoring should be done
#hypophosphaetemia , #phosphorous , #electrolytes , #icu , #criticalcare , #IntensiveCare
No comments:
Post a Comment